{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:12:43Z","timestamp":1787008363785,"version":"build-2736575974"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Primary mediastinal (thymic) large B-cell lymphoma (PMBL) is an uncommon large B-cell neoplasm recognized by the World Health Organization as a distinct entity on the basis of its unique clinical features, histogenesis, phenotype, and pathogenetic mechanisms. The diagnosis of PMBL can be challenging because of features that may overlap with other (Hodgkin and non-Hodgkin) lymphoma types. This review describes our approach to the diagnosis of PMBL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two cases are presented to illustrate how we diagnose PMBL and separate PMBL from related histologic and biological mimickers, such as Hodgkin lymphoma and gray zone lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A diagnosis of PMBL requires correlation of morphology and immunophenotype with clinical and staging data. Gene expression analysis is not typically performed in clinical labs but has expanded our understanding of the functional pathways underlying this disease and helped identify biomarkers that can be translated to diagnostic practice and possibly to future therapeutic options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PMBL and closely related entities can pose diagnostic challenges. It is important to understand the borders between PMBL and other closely related lymphoma types so that patients receive successful primary treatment with curative intent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqab122","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T15:14:01Z","timestamp":1624893241000},"page":"497-512","source":"Crossref","is-referenced-by-count":7,"title":["How I Diagnose Primary Mediastinal (Thymic) Large B-Cell Lymphoma"],"prefix":"10.1093","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-2889","authenticated-orcid":false,"given":"Sarah L","family":"Ondrejka","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Cleveland Clinic , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus , Stuttgart , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"2023111820244022100_CIT0001","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/1097-0142(19821201)50:11<2486::AID-CNCR2820501138>3.0.CO;2-G","article-title":"Primary non-Hodgkin\u2019s lymphoma of the mediastinum","volume":"50","author":"Levitt","year":"1982","journal-title":"Cancer."},{"key":"2023111820244022100_CIT0002","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9343(80)90294-6","article-title":"Primary mediastinal lymphoma in adults","volume":"68","author":"Lichtenstein","year":"1980","journal-title":"Am J Med."},{"key":"2023111820244022100_CIT0003","first-page":"455","article-title":"Primary mediastinal (thymic) large B-cell lymphoma","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed","author":"Swerdlow","year":"2017"},{"key":"2023111820244022100_CIT0004","first-page":"267","article-title":"Lymphomas of the mediastinum: primary mediastinal large B-cell lymphoma","volume-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart.","author":"Klapper","year":"2015","edition":"4"},{"key":"2023111820244022100_CIT0005","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.1999.17.3.784","article-title":"Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group","volume":"17","author":"Abou-Elella","year":"1999","journal-title":"J Clin Oncol."},{"key":"2023111820244022100_CIT0006","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/asheducation-2008.1.349","article-title":"Primary mediastinal B-cell lymphoma","author":"Johnson","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"2023111820244022100_CIT0007","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood."},{"key":"2023111820244022100_CIT0008","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/gcc.20495","article-title":"Frequent occurrence of deletions in primary mediastinal B-cell lymphoma","volume":"46","author":"Kimm","year":"2007","journal-title":"Genes Chromosomes Cancer."},{"key":"2023111820244022100_CIT0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature."},{"key":"2023111820244022100_CIT0010","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood."},{"key":"2023111820244022100_CIT0011","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood."},{"key":"2023111820244022100_CIT0012","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood."},{"key":"2023111820244022100_CIT0013","first-page":"342","article-title":"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma","volume-title":"WHO Classification of Tumours of the Hematopoietic and Lymphoid Tissues.","author":"Jaffe","year":"2016"},{"key":"2023111820244022100_CIT0014","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood."},{"key":"2023111820244022100_CIT0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d\u2019Etude des Lymphomes de l\u2019Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0016","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.critrevonc.2017.01.009","article-title":"Primary mediastinal large B-cell lymphoma","volume":"113","author":"Martelli","year":"2017","journal-title":"Crit Rev Oncol Hematol."},{"key":"2023111820244022100_CIT0017","article-title":"Racial patterns of patients with primary mediastinal large B-cell lymphoma","volume":"95:e4054","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"2023111820244022100_CIT0018","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000478-198603000-00005","article-title":"Mediastinal diffuse large-cell lymphoma with sclerosis. A clinicopathologic study of 60 cases","volume":"10","author":"Perrone","year":"1986","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0019","first-page":"187","article-title":"Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy","volume":"86","author":"Zinzani","year":"2001","journal-title":"Haematologica."},{"key":"2023111820244022100_CIT0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1634\/theoncologist.11-5-488","article-title":"Primary mediastinal large B-cell lymphoma","volume":"11","author":"Savage","year":"2006","journal-title":"Oncologist."},{"key":"2023111820244022100_CIT0021","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1200\/JCO.1993.11.12.2306","article-title":"Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features","volume":"11","author":"Lazzarino","year":"1993","journal-title":"J Clin Oncol."},{"key":"2023111820244022100_CIT0022","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2018-04-791566","article-title":"How I treat primary mediastinal B-cell lymphoma","volume":"132","author":"Giulino-Roth","year":"2018","journal-title":"Blood."},{"key":"2023111820244022100_CIT0023","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1182\/asheducation-2017.1.298","article-title":"Primary mediastinal B-cell lymphoma: biology and evolving therapeutic strategies","volume":"2017","author":"Dunleavy","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"2023111820244022100_CIT0024","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med."},{"key":"2023111820244022100_CIT0025","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2013.51.7524","article-title":"[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study","volume":"32","author":"Martelli","year":"2014","journal-title":"J Clin Oncol."},{"key":"2023111820244022100_CIT0026","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med."},{"key":"2023111820244022100_CIT0027","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdj030","article-title":"Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience","volume":"17","author":"Savage","year":"2006","journal-title":"Ann Oncol."},{"key":"2023111820244022100_CIT0028","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1997.15.4.1646","article-title":"Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients","volume":"15","author":"Lazzarino","year":"1997","journal-title":"J Clin Oncol."},{"key":"2023111820244022100_CIT0029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41408-020-0312-7","article-title":"Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up","volume":"10","author":"Zhou","year":"2020","journal-title":"Blood Cancer J."},{"key":"2023111820244022100_CIT0030","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1080\/10428190310001623810","article-title":"Pathobiology of primary mediastinal B-cell lymphoma","volume":"44","author":"Pileri","year":"2003","journal-title":"Leuk Lymphoma."},{"key":"2023111820244022100_CIT0031","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0046-8177(99)90273-3","article-title":"Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases","volume":"30","author":"Paulli","year":"1999","journal-title":"Hum Pathol."},{"key":"2023111820244022100_CIT0032","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ajcp\/83.6.676","article-title":"Primary mediastinal non-Hodgkin\u2019s lymphomas: a morphologic and immunologic study of 19 cases","volume":"83","author":"Yousem","year":"1985","journal-title":"Am J Clin Pathol."},{"key":"2023111820244022100_CIT0033","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2559.1986.tb02512.x","article-title":"Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases","volume":"10","author":"Menestrina","year":"1986","journal-title":"Histopathology."},{"key":"2023111820244022100_CIT0034","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ajcp\/112.2.241","article-title":"CD30 expression is common in mediastinal large B-cell lymphoma","volume":"112","author":"Higgins","year":"1999","journal-title":"Am J Clin Pathol."},{"key":"2023111820244022100_CIT0035","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2017-01-764258","article-title":"Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial","volume":"129","author":"Zinzani","year":"2017","journal-title":"Blood."},{"key":"2023111820244022100_CIT0036","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2559.2004.01969.x","article-title":"CD23 expression in mediastinal large B-cell lymphomas","volume":"45","author":"Calaminici","year":"2004","journal-title":"Histopathology."},{"key":"2023111820244022100_CIT0037","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000478-200110000-00008","article-title":"Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0038","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood.V98.9.2762","article-title":"Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma","volume":"98","author":"Leith\u00e4user","year":"2001","journal-title":"Blood."},{"key":"2023111820244022100_CIT0039","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAI.0000000000000820","article-title":"EBV-positive primary large B-cell lymphoma: the role of immunohistochemistry and XPO1 in the diagnosis of mediastinal lymphomas","volume":"28","author":"Maracaja","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"2023111820244022100_CIT0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.pas.0000149689.75462.ff","article-title":"TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas","volume":"29","author":"Rodig","year":"2005","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0041","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol."},{"key":"2023111820244022100_CIT0042","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0043","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/98KLHRDAM5CMDHE2","article-title":"MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis","volume":"125","author":"Hsi","year":"2006","journal-title":"Am J Clin Pathol."},{"key":"2023111820244022100_CIT0044","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/modpathol.2012.129","article-title":"Utility of CD200 immunostaining in the diagnosis of primary mediastinal large B cell lymphoma: comparison with MAL, CD23, and other markers","volume":"25","author":"Dorfman","year":"2012","journal-title":"Mod Pathol."},{"key":"2023111820244022100_CIT0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000771","article-title":"Performance of a commercially available MAL antibody in the diagnosis of primary mediastinal large B-cell lymphoma","volume":"41","author":"Gentry","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0046","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","article-title":"Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins","volume":"162","author":"Pileri","year":"2003","journal-title":"Am J Pathol."},{"key":"2023111820244022100_CIT0047","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.pap.0000138144.11635.f8","article-title":"Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma","volume":"11","author":"Calvo","year":"2004","journal-title":"Adv Anat Pathol."},{"key":"2023111820244022100_CIT0048","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood.V78.3.780.780","article-title":"Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age","volume":"78","author":"Scarpa","year":"1991","journal-title":"Blood."},{"key":"2023111820244022100_CIT0049","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":"Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer."},{"key":"2023111820244022100_CIT0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":"Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood."},{"key":"2023111820244022100_CIT0051","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","article-title":"Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma","volume":"128","author":"Mansouri","year":"2016","journal-title":"Blood."},{"key":"2023111820244022100_CIT0052","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am J Hematol."},{"key":"2023111820244022100_CIT0053","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0000000000000473","article-title":"Identification of primary mediastinal large B-cell lymphoma at nonmediastinal sites by gene expression profiling","volume":"39","author":"Yuan","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0054","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","article-title":"Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival","volume":"108","author":"Roberts","year":"2006","journal-title":"Blood."},{"key":"2023111820244022100_CIT0055","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv."},{"key":"2023111820244022100_CIT0056","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood."},{"key":"2023111820244022100_CIT0057","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0002-9440(10)62569-2","article-title":"Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features","volume":"160","author":"Inagaki","year":"2002","journal-title":"Am J Pathol."},{"key":"2023111820244022100_CIT0058","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/1097-0142(19820501)49:9<1848::AID-CNCR2820490918>3.0.CO;2-Y","article-title":"Hodgkin\u2019s disease: a clinicopathologic study of 659 cases","volume":"49","author":"Colby","year":"1982","journal-title":"Cancer."},{"key":"2023111820244022100_CIT0059","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol."},{"key":"2023111820244022100_CIT0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/5.suppl_1.S7","article-title":"The interrelationship between Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas","volume":"5","author":"Jaffe","year":"1994","journal-title":"Ann Oncol."},{"key":"2023111820244022100_CIT0061","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00000478-199209000-00007","article-title":"Non-Hodgkin\u2019s lymphomas arising in patients successfully treated for Hodgkin\u2019s disease. A clinical, histologic, and immunophenotypic study of 14 cases","volume":"16","author":"Zarate-Osorno","year":"1992","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0062","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","article-title":"Gray-zone lymphoma between cHL and large B-cell lymphoma: a histopathologic series from the LYSA","volume":"43","author":"Sarkozy","year":"2019","journal-title":"Am J Surg Pathol."},{"key":"2023111820244022100_CIT0063","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12308-009-0053-9","article-title":"Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France","volume":"2","author":"Quintanilla-Martinez","year":"2009","journal-title":"J Hematop."},{"key":"2023111820244022100_CIT0064","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjh.16331","article-title":"Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma\/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases","volume":"189","author":"Aussedat","year":"2020","journal-title":"Br J Haematol."},{"key":"2023111820244022100_CIT0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/2643-3230.BCD-20-0009","article-title":"Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma","volume":"1","author":"Pittaluga","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"2023111820244022100_CIT0066","first-page":"1259","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease. A correlative in situ hybridization and polymerase chain reaction study","volume":"139","author":"Weiss","year":"1991","journal-title":"Am J Pathol."},{"key":"2023111820244022100_CIT0067","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1182\/blood.V80.2.484.484","article-title":"Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin\u2019s disease","volume":"80","author":"Herbst","year":"1992","journal-title":"Blood."},{"key":"2023111820244022100_CIT0068","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V83.6.1595.1595","article-title":"Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin\u2019s disease: association with mixed cellularity subtype and Hispanic American ethnicity","volume":"83","author":"Gulley","year":"1994","journal-title":"Blood."},{"key":"2023111820244022100_CIT0069","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.1992.tb06945.x","article-title":"EBV infection patterns in Hodgkin\u2019s disease and normal lymphoid tissue: expression and cellular localization of EBV gene products","volume":"82","author":"Hummel","year":"1992","journal-title":"Br J Haematol."},{"key":"2023111820244022100_CIT0070","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/156\/4\/497\/53522211\/aqab122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/156\/4\/497\/53522211\/aqab122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:25:08Z","timestamp":1700321108000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/156\/4\/497\/6352913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,16]]},"published-print":{"date-parts":[[2021,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqab122","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,8,16]]}}}